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Abstract
Background: The prevalence of smoking in Spain is high in both men and women. The aim of our study was to
evaluate the role of gender in the effectiveness of a specific smoking cessation intervention conducted in Spain.
Methods: This study was a secondary analysis of a cluster randomized clinical trial in which the randomization unit
was the Basic Care Unit (family physician and nurse who care for the same group of patients). The intervention
consisted of a six-month period of implementing the recommendations of a Clinical Practice Guideline. A total of
2,937 current smokers at 82 Primary Care Centers in 13 different regions of Spain were included (2003-2005). The
success rate was measured by a six-month continued abstinence rate at the one-year follow-up. A logistic mixed-
effects regression model, taking Basic Care Units as random-effect parameter, was performed in order to analyze
gender as a predictor of smoking cessation.
Results: At the one-year follow-up, the six-month continuous abstinence quit rate was 9.4% in men and 8.5% in
women (p = 0.400). The logistic mixed-effects regression model showed that women did not have a higher odds
of being an ex-smoker than men after the analysis was adjusted for confounders (OR adjusted = 0.9, 95% CI = 0.7-
1.2).
Conclusions: Gender does not appear to be a predictor of smoking cessation at the one-year follow-up in
individuals presenting at Primary Care Centers.
ClinicalTrials.gov Identifier: NCT00125905.
Keywords: gender, smoking cessation, primary health care, clinical trials
Background
Smoking has devastating effects on health [1] and is the
first avoidable cause of mortality in developed countries
[2]. In Spain, there were 53,155 deaths attributable to
tobacco use in 2006 (14.7% of all deaths occurred in
individuals > = 35 years), 47,174 in men and 5,981 in
women [3].
Over the last decade, global tobacco consumption has
decreased progressively in Spain; however, tobacco con-
sumption remains high. According to data from 2006,
21.5% of women and 31.6% of men older than 16 were
current smokers in Spain [4]. Specifically, until the
1970s, the prevalence of smoking in women was lower
than 5%. Tobacco consumption in women has since
increased, reaching peak levels around 1995 and 2001,
and falling slightly in the following decade. In men,
tobacco consumption began to decrease after the mid
1970s [5].
In light of this prevalence of smoking in both genders,
it is necessary to implement specific intervention pro-
grams for smoking cessation in Primary Care Units.
Until recently, tobacco control initiatives have not dif-
ferentiated between the two gender groups; however,
attitudes, perceptions and behaviors related to tobacco
consumption patterns and cessation can differ between
m e na n dw o m e n[ 5 - 8 ] .T h e r e fore, knowledge of the
mechanisms by which gender influences abstinence
could provide targets for intervention [9].
Interventions aimed at smoking cessation are some-
times based on models such as the Transtheoretical
Change Model [10]. According to this model, smoking
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tional stages of change, from no intention to quit to
maintaining smoking cessation [11]. From the point of
view of the Transtheoretical Change Model, many fac-
tors, such as attitude, social influence, self-efficacy,
employment, age, marital status and gender, among
others, could be key factors in determining behavior and
change of stage.
The main purpose of this project was to evaluate gen-
der as a predictor of smoking cessation in a smoking
cessation intervention ("Intervención Sistemática sobre
Tabaquismo en Atención Primaria de Salud- ISTAPS”)
using motivational interviews and the stages of change
model [12]. Additionally, we assessed potential differ-
ences in the pattern of tobacco use by gender at baseline
and at one year after inclusion in the study.
Methods
This article is based on the ISTAPS study.
ISTAPS study
The ISTAPS Study evaluated the effectiveness of a
stepped smoking cessation intervention based on Pro-
chaska and DiClemente’s Transtheoretical Change
Model [10]. This study was a cluster randomized clinical
trial in which the randomization unit was the “Basic
Care Unit” (BCU). A BCU comprises a family physician
a n dan u r s ew h oa r ei nc h a r g eo ft h ec a r ef o rag i v e n
population of patients. Subjects were recruited from 82
Primary Health Care Centers in 13 regions of Spain.
The intervention consisted of a six-month period of
structured and systematic recommendations implemen-
ted from a Clinical Practice Guideline based on the “ces-
sation-induction trials” model proposed by Hughes et al
[13], including: motivational counseling for smokers at
the precontemplation/contemplation stage; brief inter-
v e n t i o nf o rs m o k e r si np r e p a r a t i o n / a c t i o nw h od i dn o t
want help; intensive intervention with drug therapy for
smokers in preparation/action who wanted help; and
reinforcing intervention in the maintenance stage. The
guidelines that served as the basis of the intervention
had been published recently [14]. The control group
received usual care (standard care), including smoking
cessation counseling offered in primary care to patients
with diseases related to tobacco consumption. This is
enterely free of charge, as the Spanish National Health
Service (NHS) provides universal medical coverage and
is financed essentially by general taxes. The usual care
could also include drug therapies, although these treat-
ments were not covered by the National Health Service.
Information related to process of change, decisional
balance, self-efficacy and quality of life was collected
through telephone interviews. Information related to
socio-demographics, lifestyles and pattern of tobacco
consumption was collected through personal interviews.
Finally, clinical information was collected from the sub-
jects’ medical records. Informed consent to participate
was obtained from all study subjects.
The follow-up period was two years from the start of
the intervention. For this project, we have restricted our
analysis to the first year of follow-up.
Definitive approval from the Clinical Ethics Commit-
tee of the IDIAP Jordi Gol has been granted for the
ISTAPS project (P02/13).
Detailed information about the ISTAPS project has
been published previously [12].
Study population
Our population was based on 2,937 subjects between 14
and 75 years of age from the ISTAPS study, recruited
from 2003 to 2005. Subjects were individuals who pre-
sented at Primary Health Care Centers for any reason
and answered “yes” to the question: “Do you smoke
cigarettes?”. Of 2,937 subjects, 2,827 with valid informa-
tion were selected for the analysis.
Data collection
Baseline information on socio-demographics, lifestyles,
tobacco use, stages of change, nicotine dependence
(Fagerström test scores) [15], motivation to quit (Rich-
mond test scores) [16], confidence in quitting, impor-
tance of quitting and readiness to quit as defined by
Rollnick et al [17] was collected through personal ques-
tionnaires administered by the doctor or nurse in the
Primary Care Center.
Age in years, age at smoking initation, alcohol con-
sumption, number of cigarettes per day, Fagerström and
Richmond test scores, importance of quitting smoking,
confidence in quitting smoking and readiness to quit
smoking, measured using a scale from 0 (lowest) to 10
(highest), were analyzed as continuous variables. The
measure of alcohol consumption was based on the stan-
dard unit of alcohol (1 unit = 10 gr). Alcohol consump-
tion was measured as standard units of alcohol per
week.
It is interesting to mention the Richmond test. This
test is used very widely in Spain and was described by
RL. Richmond in 1993. The test measures the smoker’s
motivation to quit smoking.
Social class was categorized according to the British
Registrar General’s Social Classification (2000) and codi-
fied into two categories (I-II: professionals, managerial
and technical occupations/III-V: non-manual skilled and
manual skilled occupations, partly skilled and unskilled
occupations) [18]. Physical exercise (leisure time) was
also classified into two categories, one for subjects who
exercised at least once a week versus those who did not
exercise at all. Categorical variables also included: group
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no), smoker friends (yes/no), stage of change (pre-con-
templation: the individual has no intention to change
behavior in the next six months; contemplation: the
individual recognizes the benefits of changing and is
considering taking action in the next six months; pre-
paration: the individual has decided to make a change in
the next 30 days; action: the individual is actively
engaged in changing their behavior), number of previous
smoking cessation attempts lasting at least 24 hours
(from 0 to 5), reduction in the number of cigarettes
consumed over last month (yes/no) and presence of
tobacco related disease (yes/no). The maintenance and
relapse stages were not considered since the study
focused on active smokers. A few subjects were in the
action stage at baseline because they gave up smoking
between the recruitment day and the interview day.
Some study subjects (21% of men and 19.4% of
women) received treatment during the study period.
Treatment was defined as both drug therapy and sup-
plemental treatments, such as anti-anxiety agents, can-
dies, regular gums and books. Drug therapy included
medications such as bupropion and nicotine substitutes
(gums and patches) that were part of the intervention.
Since the intervention is considered as an indivisible
whole, the impact of treatment on the primary outcome
cannot be known. The control group, which included
brief advice for smokers, also used these drug therapies
in some cases, but not in the same protocolized way as
in the intervention group. For this reason, a greater use
of pharmacological treatment in the intervention than
the control group is normal and desirable. Thus, treat-
ment could not be included as a separate variable
because it was assessed basically as a part of the inter-
vention or usual care.
The dichotomous outcome variable was selected, com-
paring those patients who had been ex-smokers for at
least six months of continuous abstinence (self-reported)
versus those who were current smokers at the end of
study period (one year). Subjects who were former smo-
kers for less than six months were considered smokers
Initially all subjects were asked to confirm their self-
reported abstinence on the expired air carbon monoxide
test. Smoking abstinence was considered to be con-
firmed at a carbon monoxide level lower than 10 ppm.
Only 12% of former smokers could be confirmed
biochemically.
Data analysis
Differences in socio-demographics, lifestyles and tobacco
characteristics at baseline and at one-year follow-up
were assessed in men versus women using the chi-
square and Student’s t-test or Mann-Whitney U as
appropriate.
Linear regression models were used to assess the inde-
pendent predictor variables on number of cigarettes con-
sumed last month in men, importance, confidence and
readiness to quit at the one-year follow-up in both gen-
ders, adjusted for baseline measurement. The standard
errors were adjusted for the cluster effect of the BCU.
Because significant variability among BCUs was found in
the number of cigarettes consumed last month in women,
a linear mixed-effects model was performed to assess the
independent predictors on number of cigarettes consumed
last month. These analyses were stratified by gender.
The initial individual variables considered were study
group, age, social class, alcohol intake, physical exercise,
number of cigarettes consumed last month, Fagerström
test scores, Richmond test scores, smoker partner,
smoking reduction over last month, importance of quit-
ting smoking, confidence in quitting smoking, readiness
to quit smoking and tobacco-related disease.
All subjects were included in the groups to which they
were randomized and an intention-to-treat analysis was
performed. Additionally, subjects lost to follow-up were
considered unsuccessful in their attempt to quit smok-
ing and therefore current smokers, which is the standard
approach in smoking cessation intervention studies [19].
A logistic mixed-effects model was performed to
assess gender as a predictor of continuous smoking
abstinence, accounting for clustering at the level of BCU
[20]. We used the binomial logit link with full maximum
likelihood method of estimation via the adaptative Gaus-
sian quadrature with fifty integration points.
We modeled individuals (level-1 units) as nested
within BCUs (level-2 units).
Initially we examined whether there was significant
variability among BCUs in the likelihood of smoking
cessation fitting an unconditional model with no predic-
tors at either level. As significant variation existed
between BCUs, we built a conditional model adding
level-1 individual fixed effects. We did not consider con-
textual variables at the BCU level.
The initial regression model was adjusted for gender,
study group, age, social class, alcohol intake, physical
exercise, age at smoking initation, number of cigarettes
consumed last month, Fagerström test scores, Richmond
test scores, smoker partner, smoker friends, stage of
change, number of previous smoking cessation attempts
lasting at least 24 hours, reduction of number of cigar-
ettes consumed over the last month, importance of quit-
ting smoking, confidence in quitting smoking, readiness
to quit smoking and tobacco-related disease. The
method recommended by Raudenbaush & Bryck (2002)
[21] was followed to select a subset of covariates to
include in the final regression model. The authors
checked for confounders and multi-colinearity among
the independent variables. Homogeneity of the group
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this interaction was not included in the model.
The alternative models were compared using the par-
tial likelihood ratio test and Akaike’s information criter-
ion (AIC) to determine which model provided the best
fit for the data. All results were expressed with their
95% confidence intervals (CIs) Statistical significance
was set at p < 0.05 (two-tailed).
Data were managed using the ACCESS databases, and
statistical analysis was performed using the SPSS statisti-
cal package for Windows, version 13.0 (SPSS Inc., Chi-
cago IL) and Stata/SE version 11.1 statistical package
(Stata Corp).
Results
A flow chart of clusters and individual participants
through each phase of the study is shown in figure 1.
Of the 2,827 subjects considered for this analysis, 50%
w e r em e na n dt h em e a na g ew a s4 2 . 8( S t a n d a r dD e v i a -
tion = 13.6).
At baseline, men were significantly older and con-
sumed more alcohol than women. Men also started to
smoke earlier, consumed more tobacco and had higher
nicotine dependence than women. There were more
men than women in the preparation and action stages,
and men were more confident and prepared to quit
than women (Table 1). When the analysis was stratified
by study group (Table 2), differences were found
between men and women in both groups at baseline.
The difference in the Fagerström test scores was statisti-
cally significant in the control group (p = 0.004), and
stage, confidence in quitting and readiness to quit were
only statistically significant in the intervention group (p
= 0.010, p < 0.001, and p = 0.048 respectively). The key
changes between genders among current smokers inter-
viewed one year after their inclusion in the study were
differences in confidence in quitting, which were
observed in the control group (p = 0.044) but not in the
intervention group (p = 0.206).
The variables associated with number of cigarettes per
day, importance, confidence and readiness to quit of
smokers at the one-year follow-up showed differences
between men and women (Table 3). The most impor-
tant difference is that physical exercise reduces signifi-
cantly the number of cigarettes consumed daily in
women. Differences between men and women for the
remaining predictor variables are of lesser magnitude.
Baseline values for each variable considered are highly
significant predictors.
The abstinence rate (point prevalence) at the one-year
follow-up was 18.2% in the intervention group versus
13.8% in the control group (p = 0.002). By gender, the
abstinence rate (point prevalence) was 17.2% for men
and 15% for women (p = 0.118).
At the one-year follow-up, the six-month continuous
abstinence rate was 11.3% and 6.3% in the intervention
and control group respectively (p < 0.001). By gender,
the rates were 9.4% for men and 8.5% for women (p =
0.400).
The logistic mixed-effects model showed that women
had non-significant lower odds of being an ex-smoker
than men after the analysis was adjusted for study
group, age, alcohol intake, number of cigarettes per day,
Fagerström test scores, Richmond test scores, confi-
dence in quitting and readiness to quit smoking at base-
line (adjusted OR = 0.9, 95% CI = 0.7-1.2). Statistically
significant variability was found between BCUs (variance
= 0.2, 95% CI = 0.1-0.7) (Table 4).
Discussion
This study focused on the role of gender as a potential
predictor of smoking cessation after controlling for
potential confounders such as age and amount smoked,
among other variables.
This study, which was carried out in a large number
of sites, was aimed primarily at assessing the role of
gender rather than focusing on the effect of the inter-
vention, as tobacco consumption in Spain is increasing
among women.
Therefore, gender differences were consider in socio-
demographic and lifestyle factors, as well as in the pat-
terns of tobacco use. Almost all p values between gen-
ders in Table 1 were statistically significant. Part of this
effect was due to the large sample size of our study;
however, this effect was also partly due to the existence
of a gender pattern in socio-demographic and socio-eco-
nomic variables, as described in the Spanish National
Health Survey conducted in 2006 [4].
Females had different habits than males in relation to
tobacco consumption; for example, men started to
smoke at a younger age, and their consumption of cigar-
ettes per day was higher than in women, as has been
reported in other studies [9,22,23]. Men also had greater
nicotine dependence; as many studies have demon-
strated, nicotine addiction is the main barrier to cessa-
tion [1,24]. Although women seem to be more
conscious of their health, the six-month continuous
abstinence rate was slightly higher in men than in
women, as reported previously [25,26]. However, this
difference observed between genders in our study was
not statistically significant. In the univariate analysis,
men were more confident and ready to quit smoking
than women [9]. In this study, male smokers were older
than female smokers, which reflects the actual situation
in the Spanish population [4]. The difference observed
in the levels of confidence and readiness to quit between
genders could stem from the fact that men were older
than women and that there is a clear tendency to quit
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conducted in Britain [27].
The existing evidence regarding gender and smoking
cessation interventions has so far been diverse. Studies
by Bohadana et al., Pogun et al. and others authors
show that the male gender, among other factors, is
usually considered to be a predictor of a successful out-
come in smoking cessation [25,28-30]. Women seem to
resort to smoking to confront difficult situations that
cause anxiety or depression. Furthermore, women who
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Figure 1 Flowchart of the ISTAPS study.
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Page 5 of 12are concerned about post-cessation weight gain are less
motivated to quit smoking [31,32]. These factors may
contribute to the observation that women have poorer
smoking cessation outcomes. Another reason that could
explain why women are not as successful in smoking
cessation is the poorer effect of nicotine replacement
therapies in women. A number of studies show that
more men than women quit smoking after using
Table 1 Distribution of socio-demographic information, lifestyle information and tobacco consumption characteristics
according to gender at baseline.
Total Men (%) Women (%) p-value
Sample size (n) 2827 1413 (50) 1414 (50)
group
control 1345 699 (47.3) 676 (47.8)
intervention 1482 744 (52.7) 738 (52.2) 0.806
age (years), mean (SD) 42.8 (13.6) 45.9 (14.5) 39.7 (11.8) <0.001
social class
I-II 491 236 (17.4) 255 (20.1)
III-V 2131 1120 (82.6) 1011 (79.9) 0.073
alcohol intake*, mean (SD) 6.0 (10.3) 9.2 (12.7) 2.8 (5.9) <0.001
physical exercise
never 1569 760 (54.3) 809 (57.9)
≥ 1 per week 1228 639 (45.7) 589 (42.1) 0.059
age at smoking initation, mean (SD) 16.7 (4.5) 16.0 (3.9) 17.5 (5.0) <0.001
n° cig/day, mean (SD) 20.4 (10.8) 22.1 (11.5) 18.7 (9.8) <0.001
Fagerström test scores, mean (SD) 4.5 (2.5) 4.6 (2.5) 4.3 (2.5) 0.002
Richmond test scores, mean (SD) 6.3 (2.7) 6.3 (2.7) 6.2 (2.7) 0.191
smoker partner
yes 1183 499 (41.2) 684 (59.6)
no 1174 711 (58.8) 463 (40.4) <0.001
smoker friends
yes 2477 1242 (89.7) 1235 (89.4)
no 288 142 (10.3) 146 (10.6) 0.788
stage
pre-contemplation 643 326 (23.4) 317 (22.9)
contemplation 1455 688 (49.5) 767 (55.4)
preparation 554 302 (21.7) 252 (18.2)
action 123 75 (5.4) 48 (3.5) 0.002
No. of previous attempts to quit lasting ≥ 24 hrs
0 812 356 (25.6) 456 (32.8)
1 511 254 (18.2) 257 (18.5)
2 403 186 (13.4) 217 (15.6)
3 298 153 (11.0) 145 (10.4)
4 170 87 (6.3) 83 (6.0)
5 588 356 (25.5) 232 (16.7) <0.001
reduction no. cig over last month
yes 1453 722 (52.2) 731 (53.2)
no 1303 660 (47.8) 643 (46.8) 0.614
importance of quitting smoking (rank 0-10), mean (SD) 7.8 (2.6) 7.8 (2.6) 7.9 (2.5) 0.169
confidence in quitting smoking (rank 0-10), mean (SD) 4.9 (3.1) 5.1 (3.1) 4.6 (3.2) <0.001
readiness to quit smoking (rank 0-10), mean (SD) 5.1 (3.1) 5.4 (3.1) 4.8 (3.1) <0.001
tobacco-related disease
yes 1171 692 (52.0) 479 (36.2)
no 1481 638 (48.0) 843 (63.8) <0.001
ISTAPS study.
SD: Standard Deviation
* measure: standard unit of alcohol per week (1 unit = 10 gr) (no drinkers included)
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NRTs are less effective in female smokers [33]. How-
ever, it has been reported that women and men bene-
fited equally from treatment with Bupropion [34]. It
should be emphasized that NRTs or bupropion cannot
be assessed for individual effectiveness on smoking ces-
sation in our study, since these treatments were consid-
ered to be a part of the intervention.
However, in a group of studies, no gender differences
were found in the abstinence rates [22,35]. When gender
was adjusted for potential confounders, no gender dif-
ferences in smoking cessation were found as we have
observe in our study [23,36]. Using evidence from stu-
dies that vary in design, sample characteristics, and
intensity of the interventions studied, researchers to
date have not found consistent gender-specific
differences in the effectiveness of intervention programs
for tobacco cessation.
Other studies have reported that females are more
likely to have achieved a six-month abstinence [35], per-
haps because the higher percentage of female smokers
responding to follow-up [37]. Nevertheless, many studies
have not reported cessation results by gender [36].
There is limited information related to importance,
confidence and readiness to quit smoking and gender
differences in the literature. Specifically, there is no lit-
erature regarding the predictors that could increase the
importance of quitting, self-confidence in quitting and
readiness to quit at one-year follow-up. Some gender
differences were observed in these variables at one-year
follow-up in our study, but further research is warranted
to support these results.
Table 2 Differences between genders in control and intervention groups at baseline and at one-year follow-up.
Baseline (restricted to individuals from whom information is available at one year)
Control n (%) = 703 (48.2) Intervention n (%) = 754 (51.8)
total men women p-value total men women p-value
no. cig/day, mean (SD) 20.2 (10.6) 22.1 (11.6) 18.7 (9.4) <0.001 20.7 (10.5) 22.1 (10.9) 19.5 (10.0) 0.001
Fagerström test scores, mean (SD) 4.5 (2.5) 4.8 (2.6) 4.3 (2.5) 0.004 4.7 (2.5) 4.6 (2.5) 4.7 (2.5) 0.609
Richmond test scores, mean (SD) 6.0 (2.7) 6.1 (2.7) 5.9 (2.8) 0.198 6.2 (2.8) 6.2 (2.8) 6.3 (2.7) 0.755
stage
pre-contemplation 176 73 (3.3) 103 (27.3) 178 92 (27.6) 86 (21.0)
contemplation 376 166 (53.0) 210 (55.7) 397 156 (46.8) 241 (58.9)
preparation 121 64 (20.4) 57 (15.1) 139 69 (0.7) 70 (17.1)
action 17 10 (3.2) 7 (1.9) 0.151 28 16 (4.8) 12 (2.9) 0.010
reduction no. cig over last month
yes 365 174 (55.1) 191 (50.1) 370 153 (47.2) 217 (53.8)
no 332 142 (44.9) 190 (49.9) 0.194 357 171 (52.8) 186 (46.2) 0.076
importance of quitting smoking, mean (SD) 7.7 (2.6) 7.6 (2.5) 7.8 (2.6) 0.181 7.7 (2.6) 7.6 (2.8) 7.9 (2.5) 0.195
confidence in quitting smoking, mean (SD) 4.4 (3.1) 4.5 (3.0) 4.3 (3.1) 0.474 4.8 (3.1) 5.2 (3.0) 4.4 (3.1) <0.001
readiness to quit smoking, mean (SD) 4.6 (3.0) 4.8 (2.9) 4.5 (3.1) 0.146 4.9 (3.1) 5.2 (3.2) 4.7 (3.0) 0.048
One-year follow-up
Control n (%) = 703 (48.2) Intervention n (%) = 754 (51.8)
total men women p-value total men women p-value
no. cig/day, mean (SD) 16.9 (9.9) 18.3 (11.2) 15.8 (8.5) 0.009 15.9 (9.5) 17.0 (10.5) 15.1 (8.6) 0.013
Fagerström test scores, mean (SD) ––– –––
Richmond test scores, mean (SD) ––– –––
stage
pre-contemplation 226 97 (30.7) 129 (33.8) 219 97 (28.8) 122 (29.3)
contemplation 252 112 835.4) 140 (36.6) 307 129 (38.3) 178 (42.8)
preparation 220 107 (33.9) 113 (29.6) 0.454 227 111 (32.9) 116 (27.9) 0.283
reduction no. cig over last month
yes 348 157 (49.7) 191 (50.5) 382 168 (50.3) 214 (51.8)
no 346 159 (50.3) 187 (49.5) 0.824 365 166 (49.7) 199 (48.2) 0.680
importance of quitting smoking, mean (SD) 8.0 (2.5) 8.0 (2.4) 8.1 (2.5) 0.524 8.0 (2.4) 7.9 (2.4) 8.0 (2.4) 0.749
confidence in quitting smoking, mean (SD) 4.3 (3.1) 4.5 (3.0) 4.1 (3.1) 0.044 4.2 (2.9) 4.4 (2.9) 4.1 (2.9) 0.206
readiness to quit smoking, mean (SD) 4.3 (2.9) 4.7 (2.9) 4.0 (3.0) 0.002 4.4 (2.9) 4.8 (3.0) 4.1 (2.8) 0.001
Only smokers. ISTAPS study.
SD: Standard Deviation
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Page 7 of 12Table 3 Independent predictors of no. cig/day, importance of quitting, confidence in quitting and readiness to quit at
one-year follow-up.
Men
one-year follow-up
N°cig/day importance of quitting Confidence in quitting Readiness to quit
Coefficient
(robust SE
†)
Coefficient
(robust SE
†)
Coefficient
(robust SE
†)
Coefficient
(robust SE
†)
no. cig/day 0.5 (0.05)***
Fagerström test scores 0.7 (0.19)*** -0.3 (0.05)*** -0.2 (0.05)**
Richmond test scores 0.2 (0.05)***
importance of quitting 0.2 (0.04)***
confidence in quitting 0.3 (0.04)*** 0.2 (0.05)**
readiness to quit -0.4 (0.12)*** -0.1 (0.04)* 0.1 (0.05)**
Women
one-year follow-up
N°cig/day
‡ Importance of quitting Confidence in quitting Readiness to quit
Coefficient
(SE)
Coefficient
(robust SE
†)
Coefficient
(robust SE
†)
Coefficient
(robust SE
†)
physical exercise > = 1 per week [ref.never] -1.8 (0.49)***
no. cig/day 0.4 (0.03)***
Fagerström test scores 0.4 (0.13)*** -0.2 (0.04)*** -0.2 (0.04)***
Richmond test scores 0.1 (0.04)***
Importance of quitting 0.3 (0.04)***
confidence in quitting -0.2 (0.10)* -0.1 (0.03)*** 0.3 (0.04)***
readiness to quit -0.2 (0.10)* 0.2 (0.04)***
Linear regression model. ISTAPS study
SE: standard error
Predictors variables were measured at baseline
Final models were adjusted only for significant variables.
* p ≤ 0.05
** p ≤ 0.01
***p ≤ 0.001
† The standard errors were adjusted for the cluster effect of the Basic Care Unit
‡ Linear mixed-effects model
Table 4 Predictors of smoking cessation (ex-smokers versus smokers).
Unadjusted OR (CI 95%) Adjusted OR (CI 95%) p-value
Fixed effects
gender
men 1 1
women 0.9 (0.7-1.2) 0.9 (0.7-1.2) 0.696
group
control 11
intervention 1.9 (1.4-2.6) 1.7 (1.2-2.4) 0.001
age (years) 1.0 (1.0-1.0) 1.0 (1.0-1.0) 0.011
alcohol intake 0.9 (0.9-1.0) 0.9 (0.9-1.0) 0.003
no. cig/day 1.0 (1.0-1.0) 1.0 (1.0-1.0) 0.003
Fagerström test scores 0.9 (0.9-1.0) 0.9 (0.8-0.9) <0.001
Richmond test scores 1.2 (1.1-1.2) 1.1 (1.0-1.2) 0.002
confidence in quitting smoking 1.1 (1.1-1.2) 1.1 (1.0-1.1) 0.091
readiness to quit smoking 1.2 (1.1-1.2) 1.1 (1.0-1.1) 0.207
Random effects parameter Estimate (95%CI)
Variance (BCU) (2 level) 0.2 (0.1-0.7)
Logistic mixed-effects model. ISTAPS study.
Final model were adjusted for significant and/or confounder variables
Likelihood ratio test vs logistic regression p = 0.0137
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Page 8 of 12Study strengths and limitations
In this study, which included several important factors
associated with smoking cessation, the effect of gender
was adjusted for confounding factors. Moreover, our
study took into account the design effect in the calcula-
tion of the sample size, as well as the clustering of indi-
viduals within BCUs in the analysis.
Another strength of the study is the large number of
participants. Furthermore, the study has great external
validity since it was undertaken in several regions of
Spain. All of the procedures were standardized, and all
participating sites were coordinated by the same coordi-
nating center. In addition, the professionals of both
study groups received training before beginning the
study. E-mails were sent each week, and meetings were
held periodically to ensure continuity and quality of the
study procedures.
Also, this study is one of the few to analyze gender
when transtheoretical measures are included as predic-
tor variables [9].
Some limitations of this study should be noted in
interpreting the findings. One of the limitations was the
recall bias related to dates. Patients may not have cor-
rectly remembered dates that were used in data collec-
tion, such as when they quit smoking. However, recall
bias is normal in studies that use self-reported data.
The fact that patients were asked if they wanted to
participate in the study could have had a therapeutic
effect that improved their willingness to quit smoking.
However, this therapeutic effect is present in both the
control and the intervention groups, and in both
genders.
There were only two time points of data collection,
with a one-year interval [24]. Therefore, we do not have
complete information about process or attitudes in the
middle of the study period.
An important limitation in this study is the percentage
of subjects lost to follow-up. Because the percentages of
subjects lost to follow-up are similar in both groups
(32.4% in the intervention group and 34.6% in the con-
trol group) and a penalizing data input method was
used (subjects lost to follow-up were considered to be
smokers), we do not believe this to represent a bias for
estimating the relative effect of the intervention. How-
ever, this does result in a bias for estimating the abso-
lute effect of both the intervention and the standard
care administered in the control group. Indeed, if the
analysis was performed only with subjects who were fol-
lowed, the point abstinence rate at one year would be
24.5% in the intervention group and 20.1% in the con-
trol group. The actual abstinence rate is believed to lie
s o m e w h e r eb e t w e e nt h a tv a l u ea n dt h em o r ec o n s e r v a -
tive one which was reported in the Results section
above. Additionally, we believe that this percentage of
dropouts may result from the complexity of the study,
which was conducted at 82 healthcare centers in several
regions of Spain and was incorporated to the routine of
the visits. According to the CONSORT guidelines, all
cases should be assessed as originally allocated to their
study group under an intention-to-treat approach, and
data for missing subjects should be input using the most
suitable method, especially when there is a similar per-
centage of dropouts in both groups. In any case, no
input method is free of bias.
One of the theoretical foundations for the study was
the stages of change model. It is unclear how much
time is needed to change a particular behavior, since
not many differences were found in the stages of change
between the baseline interview and the one-year
interview.
Conclusions
We can conclude that gender does not appear to be a
predictor of smoking cessation in individuals presenting
at Primary Care Centers in Spain when the effect is
adjusted for potential confounders. Further educational
and public health campaigns are needed to encourage
the use of pharmacological and non-pharmacological
interventions in both genders. The study of characteris-
tics associated with tobacco abstinence is important for
assisting health care providers in tailoring interventions
and for improving the quality of clinical services pro-
vided [37].
T h i ss t u d ys e r v e sa sab a s i sf o rt h ei n t e r v e n t i o nu s e d
today in many Spanish Primary Care Centers, and some
of the assessments proposed have been included in the
clinical practice.
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